Rehabilitation and surgical management of ankylosing spondylitis

被引:9
作者
Lubrano E. [1 ]
Astorri D. [1 ]
Taddeo M. [1 ]
Salzmann A. [1 ]
Cesarano E. [2 ]
Brunese L. [3 ]
Giganti M. [4 ]
Spadaro A. [5 ]
机构
[1] Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso
[2] Radiology Section, Health Service, Navy Command of Brindisi, Brindisi
[3] Academic Radiology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso
[4] Dipartimento di Scienze Chirurgiche, University of Ferrara, Ferrara
[5] UOC di Reumatologia, Dipartimento di Medicina Interna e Specialità Mediche, Sapienza - Università di Roma, Rome
关键词
Ankylosing spondylitis; Rehabilitation; Surgery;
D O I
10.1007/s12306-013-0285-9
中图分类号
学科分类号
摘要
Ankylosing spondylitis (AS) is a chronic inflammatory disease which, if untreated, may progress to severe damage of the spine with functional impairment, disability and poor quality of life. An increased mortality has been reported in AS patients compared to the general population. AS requires combined management (pharmacological and non-pharmacological) and advice by different health professionals. Even the pharmacological treatment in the last decade has dramatically changed the outcome, the severity of the disease might require a surgical approach for the hip involvement with total hip replacement, or the corrective spinal surgery. However, this surgery deserves some careful approaches since the complexity of the disease. Rehabilitation still represents a cornerstone of the global management of AS patients. The present review summarizes the state of art of surgical management of these two diseases. © 2013 Istituto Ortopedico Rizzoli.
引用
收藏
页码:S191 / S195
页数:4
相关论文
共 55 条
[11]  
Colao A., Marzullo P., Vallone G., Giaccio A., Ferone D., Rossi E., Scarpa R., Smaltino F., Lombardi G., Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months, Clin Endocrinol (Oxf), 51, 5, pp. 611-618, (1999)
[12]  
Colao A., Cannavo S., Marzullo P., Pivonello R., Squadrito S., Vallone G., Almoto B., Bichisao E., Trimarchi F., Lombardi G., Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly, Eur J Endocrinol, 148, 1, pp. 31-38, (2003)
[13]  
Colao A., Pivonello R., Scarpa R., Vallone G., Ruosi C., Lombardi G., The acromegalic arthropathy, J Endocrinol Invest, 28, 8 SUPPL., pp. 24-31, (2005)
[14]  
Musumeci G., Loreto C., Carnazza M.L., Coppolino F., Cardile V., Leonardi R., Lubricin is expressed in chondrocytes derived from osteoarthritic cartilage encapsulated in poly (ethylene glycol) diacrylate scaffold, Eur J Histochem EJH, 55, 3, (2011)
[15]  
Basile A., Tsetis D., Cavalli M., Fiumara P., Di Raimondo F., Coppolino F., Coppolino C., Mundo E., Desiderio C., Granata A., Patti M.T., Sacroplasty for local or massive localization of multiple myeloma, Cardiovasc Interv Radiol, 33, 6, pp. 1270-1277, (2010)
[16]  
Vander Cruyssen B.M., Hip involvement in ankylosing spondylitis: Epidemiology and risk factors associated with hip replacement surgery, Rheumatology (Oxf), 49, 1, pp. 73-81, (2010)
[17]  
Braun J., Van Den Berg R., Et al., 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis, Ann Rheum Dis, 70, 6, pp. 896-904, (2011)
[18]  
Van Den Berg R., Baraliakos X., Braun J., Van Der Heijde D., First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: A systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis, Rheumatology, 51, 8, pp. 1388-1396, (2012)
[19]  
Palazzi C., D'Angelo S., Lubrano E., Olivieri I., Aortic involvement in ankylosing spondylitis, Clin Exp Rheumatol, 26, 3 SUPPL. 49, (2008)
[20]  
Backhaus M., Citak M., Kalicke T., Sobottke R., Russe O., Meindl R., Et al., Spine fractures in patients with ankylosing spondylitis: An analysis of 129 fractures after surgical treatment, Orthopade, 40, pp. 922-924, (2011)